AtriCure sees FY24 EPS (82c) to (74c), consensus (78c)
PremiumThe FlyAtriCure sees FY24 EPS (82c) to (74c), consensus (78c)
2M ago
AtriCure reports Q2 EPS (17c), consensus (17c)
Premium
The Fly
AtriCure reports Q2 EPS (17c), consensus (17c)
2M ago
ATRC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ATRC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AtriCure price target lowered to $40 from $46 at Needham
PremiumThe FlyAtriCure price target lowered to $40 from $46 at Needham
5M ago
AtriCure price target lowered to $49 from $57 at Canaccord
Premium
The Fly
AtriCure price target lowered to $49 from $57 at Canaccord
5M ago
AtriCure sees FY24 adjusted EPS (74c)-(82c), consensus (74c)
Premium
The Fly
AtriCure sees FY24 adjusted EPS (74c)-(82c), consensus (74c)
5M ago
Oppenheimer medical devices analysts hold analyst/industry conference call
PremiumThe FlyOppenheimer medical devices analysts hold analyst/industry conference call
5M ago
Oppenheimer medical devices analysts hold analyst/industry conference call
Premium
The Fly
Oppenheimer medical devices analysts hold analyst/industry conference call
5M ago
Oppenheimer medical devices analysts hold analyst/industry conference call
Premium
The Fly
Oppenheimer medical devices analysts hold analyst/industry conference call
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100